Bromelain Enteric-coated Tablets
Function and Efficacy
Enzyme drugs. They can catalyze the cleavage of peptide bonds in protein molecules, decompose proteins, peptides, lipids, amides and other substances, and have anti-inflammatory and anti-edema effects.
Ingredients
Appearance
This product is enteric-coated tablets. After removing the enteric coating, light yellow or light brown powder appears.
Indication
Used for auxiliary treatment of postoperative infection, acute inflammation of joints, mastitis, mumps, cellulitis, chronic thrombophlebitis, bronchitis, pyelonephritis, etc.
Usage and Dosage
Oral: 30,000-90,000 units at a time, 90,000-120,000 units per day.
Adverse Reactions
Not clear yet.
Precautions
It is contraindicated for patients with peptic ulcer.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Pharmacodynamics: Enzyme drugs. It can catalyze the cleavage of peptide bonds in protein molecules, decompose proteins, peptides, lipids and amides, and has anti-inflammatory and anti-edema effects. It should not be used with drugs that can decompose proteins.
Storage
Keep away from light and in a cool place.
Packaging Specification
100,000 units
Validity Period
24 months
Manufacturer
Fujian Dawnrays Pharmaceutical Co., Ltd.
-
Founded in:
2000-10-10 -
Address:
No. 1399, Lihan West Avenue, Xitianwei Town, Licheng District, Putian City, Fujian Province -
Tax NO.:
913503006339063551 -
Registered Funds:
98.6948063 yuan -
Website:
-
Email: